Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Bio-Rad Laboratories, Inc.

NYSE

Market Cap.

8.26B

Avg. Volume

201.82K

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Bio-Rad Laboratories, Inc.!

Still processing it, give me a bit more time...

Bio-Rad Laboratories, Inc. News

Bio-Rad Laboratories, Inc. Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Website screenshot
HealthcareMedical - Devices
bio-rad.com

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Bio-Rad Laboratories, Inc. Earnings & Revenue

Bio-Rad Laboratories, Inc. Financials

Table Compare

Compare BIO metrics with:

   

Earnings & Growth

BIO

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

BIO

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

BIO

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

BIO

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Bio-Rad Laboratories, Inc. Income

Bio-Rad Laboratories, Inc. Balance Sheet

Bio-Rad Laboratories, Inc. Cash Flow

Bio-Rad Laboratories, Inc. Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityBuy
Return on AssetsStrong Buy
Debt/Equity RatioNeutral
Price/Earnings RatioBuy
Price/Book RatioSell

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Bio-Rad Laboratories, Inc. Executives

NameRole
Mr. Norman D. SchwartzChairman, Chief Executive Officer & President
Mr. Michael CrowleyExecutive Vice President of Global Commercial Operations
Dr. Andrew J. Last Ph.D.Executive Vice President & Chief Operating Officer
Mr. Roop K. LakkarajuExecutive Vice President & Chief Financial Officer
Matthew WernerSenior Vice President and Chief Compliance & Privacy Officer
NameRoleGenderDate of BirthPay
Mr. Norman D. SchwartzChairman, Chief Executive Officer & PresidentMale19501.25M
Mr. Michael CrowleyExecutive Vice President of Global Commercial OperationsMale1962974.94K
Dr. Andrew J. Last Ph.D.Executive Vice President & Chief Operating Officer1960682.29K
Mr. Roop K. LakkarajuExecutive Vice President & Chief Financial OfficerMale1971

--

Matthew WernerSenior Vice President and Chief Compliance & Privacy Officer

--

Bio-Rad Laboratories, Inc. Insider Trades

Date16 Dec
NameWRIGHT DARA
RoleEVP, President, CDG
TransactionAcquired
TypeM-Exempt
Shares502
Date16 Dec
NameWRIGHT DARA
RoleEVP, President, CDG
TransactionDisposed
TypeF-InKind
Shares174
Date16 Dec
NameWRIGHT DARA
RoleEVP, President, CDG
TransactionDisposed
TypeM-Exempt
Shares502
Date5 Dec
NameSCHWARTZ STEVEN D
Role10 percent owner
TransactionAcquired
TypeG-Gift
Shares49
Date5 Dec
NameSCHWARTZ STEVEN D
Role10 percent owner
TransactionAcquired
TypeG-Gift
Shares49
DateNameRoleTransactionTypeShares
16 DecWRIGHT DARAEVP, President, CDGAcquiredM-Exempt502
16 DecWRIGHT DARAEVP, President, CDGDisposedF-InKind174
16 DecWRIGHT DARAEVP, President, CDGDisposedM-Exempt502
5 DecSCHWARTZ STEVEN D10 percent ownerAcquiredG-Gift49
5 DecSCHWARTZ STEVEN D10 percent ownerAcquiredG-Gift49

Discover More

Streamlined Academy

Bio-Rad Laboratories, Inc.

NYSE

Market Cap.

8.26B

Avg. Volume

201.82K

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Bio-Rad Laboratories, Inc. News

Bio-Rad Laboratories, Inc. Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Bio-Rad Laboratories, Inc. Earnings & Revenue

Bio-Rad Laboratories, Inc. Income

Bio-Rad Laboratories, Inc. Balance Sheet

Bio-Rad Laboratories, Inc. Cash Flow

Bio-Rad Laboratories, Inc. Financials Over Time

Bio-Rad Laboratories, Inc. Executives

NameRole
Mr. Norman D. SchwartzChairman, Chief Executive Officer & President
Mr. Michael CrowleyExecutive Vice President of Global Commercial Operations
Dr. Andrew J. Last Ph.D.Executive Vice President & Chief Operating Officer
Mr. Roop K. LakkarajuExecutive Vice President & Chief Financial Officer
Matthew WernerSenior Vice President and Chief Compliance & Privacy Officer
NameRoleGenderDate of BirthPay
Mr. Norman D. SchwartzChairman, Chief Executive Officer & PresidentMale19501.25M
Mr. Michael CrowleyExecutive Vice President of Global Commercial OperationsMale1962974.94K
Dr. Andrew J. Last Ph.D.Executive Vice President & Chief Operating Officer1960682.29K
Mr. Roop K. LakkarajuExecutive Vice President & Chief Financial OfficerMale1971

--

Matthew WernerSenior Vice President and Chief Compliance & Privacy Officer

--

Bio-Rad Laboratories, Inc. Insider Trades

Date16 Dec
NameWRIGHT DARA
RoleEVP, President, CDG
TransactionAcquired
TypeM-Exempt
Shares502
Date16 Dec
NameWRIGHT DARA
RoleEVP, President, CDG
TransactionDisposed
TypeF-InKind
Shares174
Date16 Dec
NameWRIGHT DARA
RoleEVP, President, CDG
TransactionDisposed
TypeM-Exempt
Shares502
Date5 Dec
NameSCHWARTZ STEVEN D
Role10 percent owner
TransactionAcquired
TypeG-Gift
Shares49
Date5 Dec
NameSCHWARTZ STEVEN D
Role10 percent owner
TransactionAcquired
TypeG-Gift
Shares49
DateNameRoleTransactionTypeShares
16 DecWRIGHT DARAEVP, President, CDGAcquiredM-Exempt502
16 DecWRIGHT DARAEVP, President, CDGDisposedF-InKind174
16 DecWRIGHT DARAEVP, President, CDGDisposedM-Exempt502
5 DecSCHWARTZ STEVEN D10 percent ownerAcquiredG-Gift49
5 DecSCHWARTZ STEVEN D10 percent ownerAcquiredG-Gift49

Streamlined Academy

Website screenshot
HealthcareMedical - Devices
bio-rad.com

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Bio-Rad Laboratories, Inc.!

Still processing it, give me a bit more time...

Bio-Rad Laboratories, Inc. Financials

Table Compare

Compare BIO metrics with:

   

Earnings & Growth

BIO

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

BIO

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

BIO

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

BIO

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Bio-Rad Laboratories, Inc. Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityBuy
Return on AssetsStrong Buy
Debt/Equity RatioNeutral
Price/Earnings RatioBuy
Price/Book RatioSell

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More